Written by : Nikita Saha
November 6, 2023
As per the MoU, KSRTC will bear the medical tests of each of its employees costing INR 1200, or INR 2.55 Cr annually which the company will pay to Jayadeva Hospital. Reportedly, 62% of the employees will be covered by this scheme.
The Karnataka State Road Transport Corporation (KSRTC) has entered into a Memorandum of Understanding (MoU) with Sri Jayadeva Institute of Cardiology and Research to conduct ten types of cardiac medical check-ups for all its employees for five years.
This move comes after a surge in the cases of heart-related diseases among drivers and conductors at the institute. Under the MoU, KSRTC employees aged 40 and above will be benefitted.
Reportedly, KSRTC has identified over 24,600 drivers and conductors, among a total of 34,000 employees, who are prone to cardiac diseases due to the nature of their work and lifestyle.
As per the MoU, KSRTC will bear the medical tests of each of its employees costing INR 1200. The total expense per year will cost around INR 2.55 Cr which the company will pay to Jayadeva Hospital. Reportedly, 62% of the employees will be benefited by this scheme.
Further, this collaboration will work on creating awareness among employees and enable them to take precautions by conducting ten different heart -related check-ups.
Expressing his views on the collaboration, CN Manjunath, director, Sri Jayadeva Institute of Cardiovascular Sciences, said, “This scheme in the BMTC (Bengaluru Metropolitan Transport Corporation) is applicable to employees aged 45 years and above, but in KSRTC, this scheme is extended to employees of 40 years and above, which is good as persons of this age group are also prone to heart ailments.”
Manjunath further added that separate checkup and treatment facilities will be provided to KSRTC’s employees in Jayadeva’s Mysuru institute as well. Besides, facilities would also be utilised by staff working in nearby divisions.
Founded in 1983, Sri Jayadeva Institute of Cardiovascular Sciences and Research is a government-run autonomous institute. It is one of the largest single centres for heart care in Southeast Asia. The institute has been conducting various biomedical research in the fields of cardiology, cardiothoracic, vascular surgery, and cardiac anaesthesia. The institute aims to offer quality and affordable cardiac treatment to all sections of society.
According to data on "Accidental Deaths & Suicides in India" (ADSI) compiled by the National Crime Records Bureau (NCRB), the number of deaths due to heart attacks in India has remained consistently over 25,000 in the last four years, and over 28,000 in the last three years.
Therefore, in light of this, several institutes have taken proactive steps to implement various cardiac care initiatives. For instance, GE Healthcare launched an AI-powered 'Made in India' Cath Lab, known as Optima, as part of its commitment to advancing cardiac care in the country.
This advanced medical technology, diagnostics, and digital solutions company enables real-time streamlining of images and dose parameters. With this, the company aims to empower clinicians to concentrate their attention on patients, ultimately improving the quality of care.
Days back, AIIMS Delhi unveiled a free rapid cardiac MRI service for Thalassemia patients. This service, which assesses the amount of iron deposition in the cardiac muscle, can be completed in just eight minutes, transforming how thalassemia patients are screened and monitored.